Studies have revealed that Twist1 is involved in resistance to cisplatin in ovarian cancer,[42] decitabine in acute myeloid leukemia [43] and pirarubicin in bladder cancer.[44] Xu et al. This evidence concerns the gene TWIST1 and urinary bladder carcinoma.